ArticleJournal of pharmacy & bioallied sciences
From Sea to Synapse: Molecular Docking and Dynamics Study of Aplysinopsin Analogues as Selective 5-HT₂C Ligands.
Article in Journal of pharmacy & bioallied sciences. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Selective modulation of the serotonin 5-HT₂C receptor is a promising strategy for treating conditions, such as obesity and neuropsychiatric disorders. Aplysinopsins, a class of marine indole alkaloids, have emerged as potential 5-HT₂C-selective scaffolds. Objective: This work aims to assess the potential of aplysinopsin-based analogues as selective 5-HT₂C ligands. Methods: Here, we present conducted an Results: Dozens of analogues were docked into a serotonin receptor model, revealing sub-micromolar predicted binding affinities for several compounds. Top-ranked ligands, such as tubastrindole C, achieved docking scores around -12.7 kcal/mol and maintained stable binding poses in 100-ns MD simulations. Key ligand-receptor interactions included hydrogen bonding to the conserved Asp residue in the binding pocket and extensive π-π contacts with aromatic side chains. Notably, certain analogues with modest docking scores (e.g., N-propionyl-aplysinopsin) exhibited very favorable molecular mechanics generalized born surface area (MMGBSA) binding free energies, suggesting significant induced-fit effects upon binding. Predicted pharmacokinetic properties of the lead compounds were encouraging: all hits obeyed drug-likeness rules (0-1 Lipinski's rule violations) and showed high oral absorption prospects. While polar analogues had limited blood-brain barrier permeability, several top candidates displayed moderate central nervous system (CNS) penetration scores. Conclusion: These results highlight aplysinopsin-based analogues as attractive selective 5-HT₂C ligand candidates and provide molecular insights to guide future optimization and experimental validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.